Neurocrine Biosciences Inc.

01/07/2024 | Press release | Distributed by Public on 01/07/2024 12:21

Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Applications and Grants Priority Review for Crinecerfont for Pediatric and Adult Patients with CAH

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.